Crucell News
Most Popular Crucell Story
Crucell eagerly accepts $2.3B buyout offer from J&J
A year after buying a big chunk of Dutch biotech Crucell, J&J is coming back to the table with $2.3 billion to buy out the company and absorb its vaccine and drug development programs. For Read more...
Latest Headlines
- December 8, 2010
- October 20, 2010
- October 6, 2010
- September 17, 2010
- April 6, 2010
- February 9, 2010
- September 28, 2009
- January 8, 2009
- January 7, 2009
- October 3, 2008
- June 16, 2008
- February 12, 2008
- November 7, 2007
- October 15, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
